In Sudan's challenged healthcare system, blood transfusions are essential for both emergency and chronic care. However, lipemic blood, marked by elevated plasma lipids, presents underappreciated hazards that could jeopardize transfusion safety and effectiveness. This policy perspective examines the clinical, laboratory, and ethical implications of lipemic blood donations in Sudanese contexts, characterized by inadequate diagnostic infrastructure and a gap in current transfusion safety guidance. We emphasize that lipemia may interfere with certain laboratory assays and potentially affect transfusion processing, while the clinical implications remain incompletely defined. This article advocates for context-specific guidelines, pilot studies, and practical mitigation strategies to address this overlooked issue. Strengthening policy guidance on the management of lipemic donations could improve transfusion safety in healthcare facilities with limited resources.